[Federal Register Volume 84, Number 190 (Tuesday, October 1, 2019)]
[Notices]
[Pages 52135-52136]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-21319]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Noramco, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before October 31, 2019. 
Such persons may also file a written request for a hearing on the 
application on or before October 31, 2019.

[[Page 52136]]


ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. Comments and requests for hearings on 
applications to import narcotic raw material are not appropriate. 72 FR 
3417 (January 25, 2007).

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on July 18, 2019, Noramco Inc., 1550 Olympic Drive, 
Athens, Georgia 30601 applied to be registered as an importer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana Extract.......................   7350  I
Marihuana...............................   7360  I
Tetrahydrocannabinols...................   7370  I
Nabilone................................   7379  II
Phenylacetone...........................   8501  II
Thebaine................................   9333  II
Poppy Straw Concentrate.................   9670  II
Tapentadol..............................   9780  II
------------------------------------------------------------------------

    The company plans to import phenylacetone (8501), and poppy straw 
concentrate (9670) to bulk manufacture other controlled substances for 
distribution to its customers. The company plans to import an 
intermediate form of tapentadol (9780) to bulk manufacture tapentadol 
(9780) for distribution to its customers.
    The company plans to import impurities of buprenorphine that have 
been determined by DEA to be captured under drug code (9333) thebaine.
    In reference to drug codes 7360 and 7370, the company plans to 
import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No 
other activity for these drug codes is authorized for this 
registration. Placement of these drug codes onto the company's 
registration does not translate into automatic approval of subsequent 
permit applications to import controlled substances. Approval of permit 
applications will occur only when the registrant's business activity is 
consistent with what is authorized under 21 U.S.C. 952(a)(2). 
Authorization will not extend to the import of FDA approved or non-
approved finished dosage forms for commercial sale.

    Dated: September 23, 2019.
Thomas W. Prevoznik,
Acting Assistant Administrator Deputy Assistant Administrator.
[FR Doc. 2019-21319 Filed 9-30-19; 8:45 am]
 BILLING CODE 4410-09-P